Gilbert Marlowe
YOU?
Author Swipe
View article: MO802: Genetics Plays a Limited Role in ESA-Hyporesponsiveness and Haemoglobin Outcomes in End-Stage Renal Disease Patients on Haemodialysis
MO802: Genetics Plays a Limited Role in ESA-Hyporesponsiveness and Haemoglobin Outcomes in End-Stage Renal Disease Patients on Haemodialysis Open
BACKGROUND AND AIMS Patients with end-stage renal disease on haemodialysis (HD) frequently have resistance or hyporesponsiveness (hypoR) to erythropoiesis-stimulating agents (ESAs) and are also often iron deficient. Despite evidence of inc…
View article: Comparative Effectiveness of BNT162b2 versus Ad26.COV2.S for the Prevention of COVID-19 among Dialysis Patients
Comparative Effectiveness of BNT162b2 versus Ad26.COV2.S for the Prevention of COVID-19 among Dialysis Patients Open
Background mRNA-based SARS-CoV-2 vaccines have been shown to be highly effective among dialysis patients. Because individual vaccines may be differentially available or acceptable to patients, it is important to understand comparative effe…
View article: Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis
Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis Open
Significance Statement Among the general population, infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) robustly protects against subsequent reinfection. Whether this finding extends to patients with ESKD was not p…
View article: SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States
SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States Open
Seroprevalence was 5.8% among dialysis patients as of July 1, 2020. This indicates that the actual number of infections was 1.7 times greater than reported cases. This ratio is lower than reported in the general population, suggesting that…
View article: Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative
Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative Open
Introduction The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although tests to detect anti-SARS-CoV-2 antibodies have been developed, their sensitivity a…
View article: Supplementary Material for: The Impact of Midodrine on Outcomes in Patients with Intradialytic Hypotension
Supplementary Material for: The Impact of Midodrine on Outcomes in Patients with Intradialytic Hypotension Open
Background: Intradialytic hypotension (IDH) is a frequent complication of hemodialysis, and is associated with significant morbidity and mortality. Off-label use of the alpha-1 andrenergic receptor agonist midodrine to reduce the frequency…